Iconovo at CPhI in Madrid
Iconovo attended CPhI in Madrid last week which marked the start of our new collaboration with Stevanato Group and ICOcap. Truly an exiting moment and…
ICONOVO SIGNS AGREEMENT FOR DEVELOPMENT OF VACCINE AGAINST TUBERCULOSIS
Iconovo signs an agreement with McMaster University for development of vaccine against tuberculosis
The innovative Swedish medical technology company Iconovo…
Interview with Dr Orest Lastow September 2018 (only in Swedish)
Skånebolaget Iconovo utvecklar inhalatorer med tillhörande läkemedelsberedning som främst används för att behandla Astma och KOL men Iconovo besitter…
MIKAEL EKSTRÖM NEW VP DEVELOPMENT AT ICONOVO
Dr. Mikael Ekström has joined Iconovo as Vice President Development
Mikael has nearly 30 years of experience in inhalation products and has recently come…
Market analys of Iconovo by Erik Penser Bank (only in Swedish)
En välsignelse från Italien
Under kvartalet fakturerade bolaget SEKm 5,5 (7,7), vilket var under vår förväntan om SEKm 8. Avvikelsen ligger i att…
Iconovo signs an agreement with Stevanato Group regarding the manufacture, sale and distribution of ICOcap
The inhalation developer Iconovo AB (publ) announced today that the company has signed an agreement with the multinational Stevanato Group, headquartered…
Dr Orest Lastow is lecturing at Dry Powder Inhalers Annual Conference London 20-21 June 2018
The second generation of DPIs have become either established on the market or are a significant way along the approval process. These have been a great…
Interview with Dr Orest Lastow May 2018 (only in Swedish)
På Erik Penser Banks bolagsdag den 23 maj fick Finwire.tv möjligheten att intervjua Dr Orest Lastow, VD på Iconovo. Se intervjun här.
Market analys of Iconovo by Erik Penser Bank (only in Swedish)
Iconovo utvecklar inhalationsprodukter primärt för behandling av astma och kroniskt obstruktiva lungsjukdomar (KOL). Gemensamt för astma och KOL är…
Dr Orest Lastow lecturing at Shenyang Pharmaceutical University
The CEO of Iconovo, Dr. Orest Lastow, was invited to Shenyang Pharmaceutical University to give one-day seminar on inhalation and inhalation product development.…
Mechanical engineer for development of medicinal inhalers at Medicon Village in Lund
Iconovo is hiring a mechanical engineer to further strengthen the full development cycle of medicinal inhalers. You already have experience from product…
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 70 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
VP Business Development
Roger Lassing
Mail: roger.lassing@iconovo.se
CEO
Johan Wäborg
Mail: johan.waborg@iconovo.se